Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19

Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC. Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19. J Infect Dis. 2024 Sep 12:jiae452. doi: 10.1093/infdis/jiae452. Epub ahead of print. PMID: 39269490.


Related Posts